2,737
Views
13
CrossRef citations to date
0
Altmetric
Article

Papain bioinspired gold nanoparticles augmented the anticancer potency of 5-FU against lung cancer

, , , , , , , & show all
Pages 109-128 | Received 15 Jan 2020, Accepted 18 Mar 2020, Published online: 07 May 2020

References

  • DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271.
  • Zarogoulidis P, Pataka A, Terzi E, et al. Intensive care unit and lung cancer: when should we intubate? J Thorac Dis. 2013;5:S407.
  • Rodzinski A, Guduru R, Liang P, et al. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci Rep. 2016;6:20867.
  • Baldo BA, Pham NH. Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev. 2013;32(3–4):723–761.
  • Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338.
  • Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther. 1990;48(3):381–395.
  • Pinedo HM, Peters GF. Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988;6(10):1653–1664.
  • Chu E, Callender MA, Farrell MP, et al. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemother Pharmacol. 2003;52:80–89.
  • Rajan S, Thirunalasundari T, Jeeva S. Anti-enteric bacterial activity and phytochemical analysis of the seed kernel extract of Mangifera indica Linnaeus against Shigella dysenteriae (Shiga, corrig.) Castellani and Chalmers. Asian Pac J Trop Med. 2011;4(4):294–300.
  • Hejazin RK, El-Qudah M. Effect of proteases on meltability and stretchability of Nabulsi cheese. Am J Agric Biol Sci. 2009;4:173–178.
  • Menard R, Khouri HE, Plouffe C, et al. A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain. Biochemistry. 1990;29(28):6706–6713.
  • Beuth J. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction? Integr Cancer Ther. 2008;7(4):311–316.
  • Verspaget HW. Proteases as prognostic markers in cancer: Proteolytic enzymes and their inhibitors influence the spread of cancer. BMJ. 1998;316(7134):790–791.
  • Gebauer F, Micheel B, Stauder G, et al. Proteolytic enzymes modulate the adhesion molecule CD44 on malignant cells in vitro. Int J Immunother. 1997;13:111–119.
  • Iram S, Zahera M, Wahid I, et al. Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence. Sci Rep. 2019;9:1–16.
  • Thambiraj S, Shruthi S, Vijayalakshmi R, et al. Evaluation of cytotoxic activity of docetaxel loaded gold nanoparticles for lung cancer drug delivery. Cancer Treat Res Commun. 2019;21:100157.
  • Graczyk A, Pawlowska R, Jedrzejczyk D, et al. Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery. Molecules. 2020;25(1):204.
  • Wang Y, Han L, Liu F, et al. Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras. Colloids Surf B Biointerfaces. 2020;188:110795.
  • Qin M, Zhang J, Li M, et al. Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions. Theranostics. 2020;10(3):1213–1229.
  • Samanta K, Setua S, Kumari S, et al. Gemcitabine combination nano therapies for pancreatic cancer. Pharmaceutics. 2019;11(11):574.
  • Khan S, Rizvi SMD, Avaish M, et al. A novel process for size controlled biosynthesis of gold nanoparticles using bromelain. Mater Lett. 2015;159:373–376.
  • Khan S, Rizvi SM, Saeed M, et al. A novel approach for the synthesis of gold nanoparticles using trypsin. Adv Sci Lett. 2014;20(5):1061–1065.
  • Rahim M, Iram S, Khan MS, et al. Glycation-assisted synthesized gold nanoparticles inhibit growth of bone cancer cells. Colloids Surf B Biointerfaces. 2014;117:473–479.
  • Bechtel TJ, Weerapana E. From structure to redox: the diverse functional roles of disulfides and implications in disease. Proteomics. 2017;17(6):1600391.
  • Hermanson GT. Information on protein crosslinking, labeling and surface attachment. Bioconjugate technique. Academic Press; 1996.
  • Cojocaru IC, Ochiuz L, Spac A, et al. The validation of the UV spectrophotometric method for the assay of 5 fluorouracil. Farmacia. 2012;3:60.
  • Haiss W, Thanh NTK, Aveyard J, et al. Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal Chem. 2007;79(11):4215–4221.
  • Iram S, Zahera M, Khan S, et al. Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin. Colloids Surf B Biointerfaces. 2017;160:254–264.
  • Kholmukhamedov A, Schwartz JM, Lemasters JJ. MitoTracker probes and mitochondrial membrane potential. Shock. 2013;39(6):543.
  • Chou T-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440–446.
  • Sun T, Zhang YS, Pang B. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed. 2014;53:12320–12364.
  • Lu A, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007;46(8):1222–1244.
  • Grisolia J, Viallet B, Amiens C, et al. 99% random telegraph signal-like noise in gold nanoparticle micro-stripes. Nanotechnology. 2009;20(35):355303.
  • Bullis K. Nanoparticle networks promise cheaper batteries for storing renewable energy. MIT Technol Rev; 2015. Available from http://www.technologyreview.com/news/526811/nanoparticle
  • Bajaj A, Miranda OR, Kim I-B, et al. Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays. Proc Natl Acad Sci USA. 2009;106(27):10912–10916.
  • Treuel L, Brandholt S, Maffre P, et al. Impact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactions. ACS Nano. 2014;8(1):503–513.
  • Leite FL, Bueno CC, Da Róz AL, et al. Theoretical models for surface forces and adhesion and their measurement using atomic force microscopy. Int J Mol Sci. 2012;13(10):12773–12856.
  • Khan S, Haseeb M, Baig MH, et al. Improved efficiency and stability of secnidazole – an ideal delivery system. Saudi J Biol Sci. 2015;22(1):42–49.
  • Famta P, Mishra V, Khatik GL. Formulation and evaluation of 5-fluorouracil and methotrexate gold nanoparticles [doctoral dissertation]. Phagwara (India): Lovely Professional University; 2017.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
  • Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284–304.
  • Wang B, Yu X-C, Xu S-F, et al. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma. J. Nanobiotechnology. 2015;13(1):22.
  • Rudnick-Glick S, Corem-Salkmon E, Grinberg I, et al. Doxorubicin-conjugated bisphosphonate nanoparticles for the therapy of osteosarcoma. JSM Nanotechnol Nanomed. 2014;1022:2.
  • Zhang Y, Yang C, Wang W, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 2016;6:21225.
  • Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627.
  • Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Nat. 2011;3(2):34–55.
  • Cho K, Wang XU, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14(5):1310–1316.
  • Hiremath CG, Kariduraganavar MY, Hiremath MB. Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting. Prog Biomater. 2018;7(4):297–306.
  • Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146.
  • da Silva CR, Oliveira MBN, Motta ES, et al. Genotoxic and cytotoxic safety evaluation of papain (Carica papaya L.) using in vitro assays. Biomed Res. Int. 2010;2010:1–8.
  • Müller A, Barat S, Chen X, et al. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. Int J Oncol. 2016;48(5):2025–2034.